| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0007 |